Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
Machtay M, Hsu C, Komaki R, Sause WT, Swann RS, Langer CJ, Byhardt RW, Curran WJ. Machtay M, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):667-71. doi: 10.1016/j.ijrobp.2005.03.037. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15927409 Clinical Trial.
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.
Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ. Machtay M, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):425-34. doi: 10.1016/j.ijrobp.2010.09.004. Epub 2010 Oct 25. Int J Radiat Oncol Biol Phys. 2012. PMID: 20980108 Free PMC article. Clinical Trial.
Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.
Komaki R, Paulus R, Ettinger DS, Videtic GM, Bradley JD, Glisson BS, Langer CJ, Sause WT, Curran WJ Jr, Choy H. Komaki R, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e531-6. doi: 10.1016/j.ijrobp.2012.01.075. Epub 2012 May 5. Int J Radiat Oncol Biol Phys. 2012. PMID: 22560543 Free PMC article. Clinical Trial.
A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04).
Bradley JD, Scott CB, Paris KJ, Demas WF, Machtay M, Komaki R, Movsas B, Rubin P, Sause WT. Bradley JD, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1173-9. doi: 10.1016/s0360-3016(01)02797-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955727 Clinical Trial.
Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience.
Machtay M, Seiferheld W, Komaki R, Cox JD, Sause WT, Byhardt RW. Machtay M, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):847-53. doi: 10.1016/s0360-3016(99)00120-0. Int J Radiat Oncol Biol Phys. 1999. PMID: 10386642 Free article.
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, et al. Sause WT, et al. J Natl Cancer Inst. 1995 Feb 1;87(3):198-205. doi: 10.1093/jnci/87.3.198. J Natl Cancer Inst. 1995. PMID: 7707407 Clinical Trial.
136 results